SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hibbett, Inc. (HIBB) trades at a trailing P/E of 10.7. Trailing earnings yield is 9.34%. PEG 0.05 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (56/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- PEG Ratio 0.05 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 9.34% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $71.10 (-18.7% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 56/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
56/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HIBB
Valuation Multiples
P/E (TTM)10.7
Forward P/EN/A
PEG Ratio0.05
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.66
EV/EBITDA0.0
Per Share Data
EPS (TTM)$8.17
Book Value / Share$0.00
Revenue / Share$131.87
FCF / Share$0.00
Yields & Fair Value
Earnings Yield9.34%
Dividend Yield0.00%
Analyst Target$71.10 (-18.7%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.92 |
$943.1M |
$70.53M |
7.5% |
| 2017 |
$2.72 |
$972.96M |
$61.08M |
6.3% |
| 2018 |
$1.71 |
$968.22M |
$35.03M |
3.6% |
| 2019 |
$1.51 |
$1.01B |
$28.42M |
2.8% |
| 2020 |
$1.52 |
$1.18B |
$27.34M |
2.3% |
| 2021 |
$4.36 |
$1.42B |
$74.27M |
5.2% |
| 2022 |
$11.19 |
$1.69B |
$174.31M |
10.3% |
| 2023 |
$9.62 |
$1.71B |
$128.06M |
7.5% |
| 2024 |
$2.74 |
$455.5M |
$35.88M |
7.9% |
| 2024 |
$8.17 |
$1.73B |
$35.88M |
2.1% |
